Establishment and characterization of a novel Chinese human lung adenocarcinoma cell line CPA-Yang2 in immunodeficient mice

Chinese Journal of Lung Cancer

Volumn 12, Issue 10, 2009, Pages 1055-1060

  Yang, Shunfang ^a   Su, Jianzhong ^b   Shi, Meiping ^a   Zhao, Lanxiang ^a   Zhang, Peiling ^a   Cao, Jie ^a   Lu, Jianying ^b   Xie, Wenhui ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b TONGJI UNIVERSITY   (China)

Author keywords

Lung neoplasms; Mice; Nude; Tumor cells

Indexed keywords

CA 125 ANTIGEN; CYTOKERATIN 19 FRAGMENT; LE(Y) ANTIGEN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASCITES; BONE SCINTISCANNING; CANCER CELL CULTURE; CANCER RECURRENCE; CELL GROWTH; GENE MAPPING; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IMMUNE DEFICIENCY; LUNG ADENOCARCINOMA; LUNG CARCINOGENESIS; METASTASIS; MOUSE; MULTIDRUG RESISTANCE; NONHUMAN; POLYMERASE CHAIN REACTION; RADIOIMMUNOASSAY;

EID: 75449099787     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: 10.3779/j.issn.1009-3419.2009.10.01     Document Type: Article

References (16)

1. American Cancer Society. Cancer facts and figures 2006. Atlanta, GA: American Cancer Society, 2006. 5-6.
2. Little AG, Gay EG, Gaspar LE, et al. National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care. Lung Cancer, 2007, 57(3): 253-260.
3. Sone S, Yano S. Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev, 2007, 26(3-4): 685-689.
4. The urban area of Shanghai in 2003 the incidence of malignant. Tumor, 2006, 26(7): 694.
5. AACR 100th Annual Meeting 2009 Proceedings. Cancer Research, 2009, 50: 1-1370.
6. Sarrazin S, Adam E, Lyon M, et al. Endocan or endothelial cell specific molecule-1 (ESM-1): a potential novel endothelial cell marker and a new target for cancer therapy. Biochim Biophys Acta, 2006, 1765(1): 25-37.
7. Furudoi A, Tanaka S, Haruma K, et al. Clinical significance of vascular endothelial growth factor C expression and angiogenesis at the deepest invasive site of advanced colorectal carcinoma. Oncology, 2002, 62(2): 157-166.
8. Wang HM, Ji X, Yu J. The related research among some cytokins and bone resorption, bone metastasis of lung cancer. Shandong Medical, 2001, 41(3): 1-3.
9. Masuya D, Huang C, Liu D, et al. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients. Cancer, 2001, 92(10): 2628-2638.
10. Yan M, Chen XB, Wang SL, et al. ER and AR expression in lung cancer. Chin Lung Cancer, 2008, 11(1): 126-129.
11. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C (T)) method. Methods, 2001, 25(4): 402-408.
12. Yang SF, Shi MP, Yao M, et al. The role of Tc-99m MDP bone dcintigraphy in establishment of a human lung adenocarcinoma cell line SPC-A-1BM which produces hbighly bone metastases in NIH-BNX Mice. Tumor, 2008, 28(11): 933-937.
13. Yang S, Dong Q, Yao M, et al. Establishment of an Experimental Human Lung Adenocarcinoma Cell Line SPC-A-1BM with Highly Bone Metastases Potency by 99mTc-MDP Bone Scintigraphy. Nucl Med Biol, 2009, 36(3): 313-321.
14. Lobo NA, Shimono Y, Qian D, et al. The biology of cancer stem cells. Annu Rev Cell Dev Biol, 2007, 23: 675-699.
15. Luzzi KJ, MacDonald IC, Schmidt EE, et al. M mu;ltistep nature of metastatic inefficiency: dormancy of solitary cells after successf+l extravasation and limited survival of early micrometastases. Am J Pathol, 1998, 153(3): 865-873.
16. Stabile LP, Siegfried JM. Estrogen receptor pathways in lung cancer. Curr Oncol Rep, 2004, 6(4): 259-267.